Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Trial Evaluating the Safety and Efficacy of Cesamet™ for the Symptomatic Treatment of Chemotherapy-Induced Neuropathic Pain in Patients With Cancer

NCT00380965 is registered in ClinicalTrials.gov with NEMA Research, Inc. as lead sponsor.

NCT NCT00380965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00380965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Trial Evaluating the Safety and Efficacy of Cesamet™ for the Symptomatic Treatment of Chemotherapy-Induced Neuropathic Pain in Patients With Cancer
Lead sponsor
NEMA Research, Inc.
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2006
Completion date
October 31, 2007
Enrollment
23 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

antineoplastic combined chemotherapy protocols, peripheral neuropathy